South Korean Biotech Introduces Fat-Based Solution for ‘Ozempic Face’

POLICY WIRE — Seoul, South Korea — South Korean biotech firm L&C Bio is set to introduce an innovative injectable skin booster made from donated human fat, aimed at addressing the cosmetic issue known as ‘Ozempic face’. This condition arises from the use of weight-loss drugs like Ozempic, which can lead to facial volume loss.

L&C Bio, a pioneer in using donated human tissue for K-beauty skin boosters, developed this technology approximately five years ago, according to CEO Lee Whan Chul. The company holds patents for this method and anticipates that the growing demand for cosmetic solutions related to weight-loss medications will fuel its next phase of growth.

‘Ozempic face’ has become a notable side effect for individuals using weight-loss drugs, prompting a surge in interest for corrective cosmetic procedures. L&C Bio’s new product is positioned to capitalize on this trend, offering a novel approach to facial volume restoration.

The company’s strategy aligns with the broader K-beauty industry’s emphasis on innovative and effective skincare solutions. By leveraging donated human fat, L&C Bio aims to provide a natural and sustainable option for those seeking to mitigate the effects of ‘Ozempic face’.

Reporting by Policy-Wire (PW)